Gavaris Leads Lupin In US Ahead Of Core Spiriva Strategy
Indian Firm Expecting Gx Tiotropium To Be Major Catalyst For Growth
Lupin praised the “strong pharma and biotech experience” of former Hikma executive Spiro Gavaris after appointing him to head up the firm’s US generics unit.
